Doubling of deaths from alcoholic liver disease - drug abuse during 1970s and 1980s may explain whyJuly 31, 2002Middle-aged men could be at increased risk of death from liver disease, as a result of illicit intravenous drug use during the 1970s and 1980s, according to a study published today. Researchers from Imperial College London studied the numbers of deaths in England from alcohol related illness between 1993 and 1999 recorded by the Office of National Statistics. They discovered that deaths from alcohol-related illness rose by 59 per cent for men, and 40 per cent for women, while deaths from unspecified alcohol liver damage rose by 259 per cent in men aged between 40 and 59 years old. A rise of this size did not occur in women of any age or younger men. Professor John Henry, from Imperial College, and based at St Mary’s Hospital, says: “Although there has been this huge rise in the numbers of deaths from alcoholic liver damage in men, there has not been a similar rise in the amount of alcohol consumed.”
“At the same time, there has been a marked increase in the number of hepatitis C cases, with up to 300,000 infected in Britain. In hepatitis C sufferers alcohol consumption has been shown to cause accelerated liver damage, a higher frequency of cirrhosis, and a higher incidence of hepatocellular carcinoma, eventually leading to death.” The researchers looked at data from the Public Health Laboratory Service which suggested that 80 per cent of hepatitis C transmission is associated with intravenous drug use. Although circumstantial, the researchers believe there is a link between this rise in the number of hepatitis C cases, and illicit intravenous drug use during the 1970s and 1980s, when hepatitis C may have been picked up through the use of infected needles. Professor Henry adds: “Although we have no evidence that men currently aged between 40 and 59 years have a higher lifetime history of illicit drug use than younger or older groups, these are people who would have been involved in the heroin epidemic of 1970s and 1980s. Significantly, this was before the introduction of needle exchange and other interventions instigated in the late 1980s to reduce the risk of HIV transmission in drug users.” Imperial College, University of London | |||||||||||||||||||||
|
Related Hepatitis Current Events and Hepatitis News Articles Childhood vaccines cause financial burden to many health care providers The costs that health care providers are charged and reimbursed for childhood vaccines vary widely, and the high cost of some immunizations is leading to significant financial strain for some physicians, according to a pair of new studies from the University of Michigan Health System. Antibiotics: Single largest class of drugs causing liver injury Antibiotics are the single largest class of agents that cause idiosyncratic drug-induced liver injury (DILI), reports a new study in Gastroenterology, an official journal of the American Gastroenterological Association (AGA) Institute. Study unmasks how ovarian tumors evade immune system Scientists at Johns Hopkins have determined how the characteristic shedding of fatty substances, or lipids, by ovarian tumors allows the cancer to evade the body's immune system, leaving the disease to spread unchecked Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models. UT Southwestern researchers develop new strategy for broad spectrum anti-viral drugs Bavituximab, an anti-viral drug developed by UT Southwestern Medical Center researchers, shows promise as a new strategy to fight viral diseases, including potential bioterrorism agents. Common cold virus came from birds A virus that causes cold-like symptoms in humans originated in birds and may have crossed the species barrier around 200 years ago, according to an article published in the December issue of the Journal of General Virology. Scientists hope their findings will help us understand how potentially deadly viruses emerge in humans. Study finds Canada's supervised injection facility cost-effective Canada's only supervised injection facility is extending lives and saving the health-care system millions of dollars, a new study shows. Tibotec presents interim findings for TMC435, an investigational genotype 1 hepatitis C treatment New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection. Mayo Clinic's new imaging technology accurately identifies a broad spectrum of liver disease A new study shows that an imaging technology developed by Mayo Clinic researchers can identify liver fibrosis with high accuracy and help eliminate the need for liver biopsies. Liver fibrosis is a common condition that can lead to incurable cirrhosis if not treated in time. Pakistan introduces vaccine to prevent top child killer This month, Pakistan is introducing a new combination vaccine that will protect its children against the bacterium Haemophilus influenzae type b (Hib) and four other common childhood diseases. More Hepatitis Current Events and Hepatitis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||